Published in Ann Pharmacother on May 01, 1999
Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study. Support Care Cancer (2007) 0.91
Docetaxel-induced onycholysis: the role of subungual hemorrhage and suppuration. Yonsei Med J (2007) 0.80
Supportive cryotherapy: a review from head to toe. J Pain Symptom Manage (2013) 0.77
Trastuzumab-Docetaxel Combination Chemotherapy Induced Severe Onychopathy. Indian Dermatol Online J (2017) 0.75
Fingerprint changes among cancer patients treated with paclitaxel. J Cancer Res Clin Oncol (2016) 0.75
Regional variations of cutaneous propionibacteria. Appl Environ Microbiol (1978) 2.00
Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol (1983) 1.67
Stereotactic Irradiation: potential new treatment method for brain metastases resulting from ovarian cancer. Am J Clin Oncol (1999) 1.41
Pathogenic JK group corynebacteria and their similarity to human cutaneous lipophilic diphtheroids. J Infect Dis (1985) 1.38
Skin microflora. J Invest Dermatol (1987) 1.33
Epithelioid angiomatosis: a distinct vascular disorder in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Lancet (1987) 1.30
Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro. Infect Immun (1985) 1.26
Regional variations in density of cutaneous propionibacteria: correlation of Propionibacterium acnes populations with sebaceous secretion. J Clin Microbiol (1980) 1.24
Use of bacteriophage typing to distinguish Propionibacterium acne types I and II. J Clin Microbiol (1978) 1.19
Headspace analysis of volatile metabolites of Pseudomonas aeruginosa and related species by gas chromatography-mass spectrometry. J Clin Microbiol (1980) 1.17
Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun (1978) 1.16
Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation (1980) 1.14
Parenteral benzyl alcohol-induced hypersensitivity reaction. Drug Intell Clin Pharm (1986) 1.09
Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. J Am Acad Dermatol (2001) 1.09
Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer (1992) 1.06
Correlation of Propionibacterium acnes populations with the presence of triglycerides on nonhuman skin. Appl Environ Microbiol (1981) 1.01
Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: A Gynecologic Oncology Group Study. J Clin Oncol (2000) 0.99
Complement activation in acne vulgaris: consumption of complement by comedones. Infect Immun (1979) 0.98
Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients. J Invest Dermatol (1980) 0.96
Use of litmus milk agar for presumptive identification of cutaneous propionibacteria. J Clin Microbiol (1977) 0.96
Plasma thrombospondin levels in patients with gynecologic malignancies. Cancer (1994) 0.95
Inhibition of lipase production in Propionibacterium acnes by sub-minimal-inhibitory concentrations of tetracycline and erythromycin. Br J Dermatol (1981) 0.91
Endocervical brush versus cotton swab for obtaining cervical smears at a clinic. A cost comparison. J Reprod Med (1993) 0.91
Direct interaction of antifungal azole-derivatives with calmodulin: a possible mechanism for their therapeutic activity. J Invest Dermatol (1993) 0.90
Analysis of cellular components, biochemical reactions, and habitat of human cutaneous lipophilic diphtheroids. J Invest Dermatol (1985) 0.90
Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions. Inflammation (1981) 0.90
Dilated fallopian tubes: MR imaging characteristics. Radiology (1998) 0.89
Doxorubicin-induced hypersensitivity reactions. Drug Intell Clin Pharm (1984) 0.87
Facial follicular porphyrin fluorescence: correlation with age and density of Propionibacterium acnes. Br J Dermatol (1980) 0.87
Acne. A review of optimum treatment. Drugs (1994) 0.86
Cytogenetic study of botryoid rhabdomyosarcoma of the uterine cervix. Virchows Arch A Pathol Anat Histopathol (1993) 0.86
Loop electrocautery excisional procedure: therapeutic effectiveness as an ablation and a conization equivalent. Gynecol Oncol (1996) 0.85
Characteristic gamma-lactone odor production of the genus Pityrosporum. Appl Environ Microbiol (1979) 0.85
Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin. Antimicrob Agents Chemother (1982) 0.84
The effect of the menstrual cycle on acne. J Am Acad Dermatol (2001) 0.83
The relationship of local and distant failure from endometrial cancer: defining a clinical paradigm. Gynecol Oncol (1997) 0.83
Spontaneous internal jugular vein thrombosis associated with leiomyosarcoma of the omentum. Gynecol Oncol (1992) 0.83
Intralesional fluorouracil/epinephrine injectable gel for treatment of condylomata acuminata. A phase 3 clinical study. Arch Dermatol (1997) 0.82
Phase I/II study of concomitant irradiation and carboplatin for locally advanced carcinoma of the uterine cervix: an interim report. Am J Clin Oncol (1996) 0.82
Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis. Am J Gastroenterol (1993) 0.81
Imaging of the ovary and adnexa: clinical issues and applications of MR imaging. Radiology (1995) 0.81
Vascular diseases are the most common cutaneous manifestations of reflex sympathetic dystrophy. J Am Acad Dermatol (2001) 0.80
Papillary projections in ovarian neoplasms: appearance on MRI. J Magn Reson Imaging (1997) 0.80
Pharmacy staff interventions in a medical center hematology-oncology service. J Am Pharm Assoc (Wash) (1998) 0.80
Antibody titers to Propionibacterium acnes cell wall carbohydrate in nodulocystic acne patients. J Invest Dermatol (1985) 0.79
Endometrial cancer in polyps associated with tamoxifen use. Am J Obstet Gynecol (1999) 0.79
Antineoplastics: a safety hazard? Am J Hosp Pharm (1981) 0.79
Autoimmune bullous disease in a patient with HIV infection. J Am Acad Dermatol (1991) 0.77
Anti-inflammatory actions of benzoyl peroxide: effects on the generation of reactive oxygen species by leucocytes and the activity of protein kinase C and calmodulin. Br J Dermatol (1994) 0.77
Topical retinoids in the treatment of acne vulgaris. Cutis (1999) 0.77
National trends in the surgical staging of corpus cancer: a pattern-of-practice survey. Obstet Gynecol (1997) 0.77
Inhibition of chemiluminescence in human neutrophils by dapsone. Br J Dermatol (1984) 0.76
Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic, and neoplastic endocervical lesions. Int J Gynecol Pathol (1997) 0.76
A method for the assay of inflammatory mediators in follicular casts. J Invest Dermatol (1979) 0.76
Aseptic technique as a safety precaution in the preparation of antineoplastic agents. Hosp Pharm (1981) 0.76
Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion. Int J Dermatol (1996) 0.76
Acne vulgaris: state of the science. Arch Dermatol (1999) 0.76
Protocol for immunocytochemical detection of SIL in cervical smears using MIB-1 antibody to Ki-67 [corrected]. Mod Pathol (1996) 0.76
The role of surgery in the management of uncommon skin infections. Dermatol Surg (1995) 0.76
Treatment of cervical carcinoma with ionizing irradiation using moving fields. J Natl Med Assoc (1991) 0.75
Serologic analysis of the extractable carbohydrate antigens of Pityrosporum ovale. Microbios (1980) 0.75
Are porokeratoses an infection? Arch Dermatol (2001) 0.75
Activation of components of the alternative pathway of complement by Propionibacterium acnes cell wall carbohydrate. J Invest Dermatol (1982) 0.75
Is it reasonable for a dermatologist to treat acne? Arch Dermatol (1996) 0.75
Comments on study of antineoplastic drug handlers. Am J Hosp Pharm (1993) 0.75
Comment: Pharmacy specialization. DICP (1990) 0.75
Colposcopy, cervicography, speculoscopy and endoscopy. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial. Acta Cytol (1998) 0.75
Comparison of standard and loupe colposcopy (part I). J Low Genit Tract Dis (1997) 0.75
Repair of vaginal vault prolapse with abdominal sacropexy. J Reprod Med (1990) 0.75
Inhibition of the classical and alternative pathways of human and guinea pig complement by pyran copolymer. Int Arch Allergy Appl Immunol (1981) 0.75
Selective calmodulin antagonists fail to inhibit phorbol ester-induced superoxide anion release from human neutrophils: effects of antifungal azole derivatives. Br J Dermatol (1996) 0.75
Stability of cisplatin, doxorubicin, and mitomycin combined with loversol for chemoembolization. Ann Pharmacother (2001) 0.75
Evaluation of the atypical cytologic smear. Validity of the 1991 Bethesda System. J Reprod Med (1994) 0.75
Instability of bleomycin in plastic containers. Am J Hosp Pharm (1982) 0.75
Demonstration of skin fluorescence following exposure to doxorubicin. Cancer Nurs (1983) 0.75
Knowledge base as a predictor of follow-up compliance after colposcopy. J Low Genit Tract Dis (1997) 0.75
Pancytopenia following low-dose oral methotrexate therapy for psoriasis. JAMA (1988) 0.75
Mycocutaneous atypical mycobacterial infections in acquired immunodeficiency syndrome. Clin Dermatol (1996) 0.75
Percutaneous abscess drainage in gynecologic cancer patients. Gynecol Oncol (1996) 0.75
Extended-field radiation therapy in early-stage cervical carcinoma: survival and complications. Gynecol Oncol (1991) 0.75
A systems approach to the problem of missing medications. Top Hosp Pharm Manage (1991) 0.75
Cutaneous involvement by an ovarian serous tumor of low malignant potential. Acta Obstet Gynecol Scand (1991) 0.75
Internet survey of colposcopy practices. J Low Genit Tract Dis (1997) 0.75
Phototoxicity from benoxaprofen: in vivo and in vitro studies. Photochem Photobiol (1982) 0.75
Acute pancreatitis associated with continuous infusion cytarabine therapy: a case report. Cancer (1996) 0.75
Methotrexate therapy in cutaneous sarcoidosis. Ann Intern Med (1989) 0.75
Comparison of Standard and Loupe Colposcopy (Part II): Initial Experience with a New 6×-10× Surgical Loupe. J Low Genit Tract Dis (1997) 0.75
Concomitant irradiation and dose-escalating carboplatin for locally advanced carcinoma of the uterine cervix: an updated report. Am J Clin Oncol (1998) 0.75
The impact of recalled elementary school height and weight on later weight concerns. Eat Weight Disord (2008) 0.75
Axillary granular parakeratosis: response to isotretinoin. J Am Acad Dermatol (1997) 0.75
Medical treatment of acne. G Ital Dermatol Venereol (2009) 0.75
Clarification on cisplatin. Clin Pharm (1983) 0.75
A comparative analysis of Ki-67, p53, and p21WAF1CIP1 expression in tamoxifen associated endometrial carcinomas. Anticancer Res (1999) 0.75
Mycobacterium intracellulare soft tissue infection. J Am Acad Dermatol (1992) 0.75
Clinical significance of histiocytes found on cervical cytology. J Low Genit Tract Dis (1999) 0.75
Cytology specimen adequacy using different papanicolaou smear techniques. J Low Genit Tract Dis (1999) 0.75
Toxic lesions of the hand associated with chemotherapy. J Hand Surg Am (1983) 0.75